title: Severe adverse skin reaction and desensitization to sorafenib.
authors.affiliation: Center of Pulmonology and Allergology, Vilnius University, Vilnius, Lithuania. Electronic address: Kotryna.linauskiene@santa.lt.
authors.forename: Kotryna
authors.initials: K
authors.lastname: Linauskiene
authors.affiliation: Center of Pulmonology and Allergology, Vilnius University, Vilnius, Lithuania.
authors.forename: Laura
authors.initials: L
authors.lastname: Malinauskiene
authors.affiliation: Hematology, Oncology and Transfusion Medicine Center, Vilnius University, Vilnius, Lithuania.
authors.forename: Edvina
authors.initials: E
authors.lastname: Vitkauskaite
authors.affiliation: Center of Pulmonology and Allergology, Vilnius University, Vilnius, Lithuania.
authors.forename: Anzelika
authors.initials: A
authors.lastname: Chomiciene
authors.affiliation: Center of Pulmonology and Allergology, Vilnius University, Vilnius, Lithuania.
authors.forename: Audra
authors.initials: A
authors.lastname: Blaziene
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy*; D048708:Cell Growth Processes / Q000187:drug effects; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy*; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D000077157:Sorafenib; D014581:Urticaria; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib